Regeneron Covid-19 antibody may help speed recovery, early data show
Experts caution more data from larger trials will be needed to know how potentially beneficial monoclonal antibodies are.
Experts caution more data from larger trials will be needed to know how potentially beneficial monoclonal antibodies are.
After falling for over a decade, the death rate climbed for several years and now is about the same as in 1999.
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
Decades of declining heart failure mortality in the U.S. has reversed, and exceeded rates recorded more than 20 years ago, according to overall population-level data…
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
Decades of declining heart failure mortality in the U.S. has reversed, and exceeded rates recorded more than 20 years ago, according to overall population-level data…
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.